Cite
A Randomized Feasibility Trial to Evaluate Use of the Jaw Dynasplint to Prevent Trismus in Patients With Head and Neck Cancer Receiving Primary or Adjuvant Radiation-Based Therapy.
MLA
Zatarain, Lauren A., et al. “A Randomized Feasibility Trial to Evaluate Use of the Jaw Dynasplint to Prevent Trismus in Patients With Head and Neck Cancer Receiving Primary or Adjuvant Radiation-Based Therapy.” Integrative Cancer Therapies, vol. 17, no. 3, Sept. 2018, pp. 960–67. EBSCOhost, https://doi.org/10.1177/1534735418784363.
APA
Zatarain, L. A., Smith, D. K., Deng, J., Gilbert, J., Dietrich, M. S., Niermann, K. J., Ridner, S. H., & Murphy, B. A. (2018). A Randomized Feasibility Trial to Evaluate Use of the Jaw Dynasplint to Prevent Trismus in Patients With Head and Neck Cancer Receiving Primary or Adjuvant Radiation-Based Therapy. Integrative Cancer Therapies, 17(3), 960–967. https://doi.org/10.1177/1534735418784363
Chicago
Zatarain, Lauren A, Derek K Smith, Jie Deng, Jill Gilbert, Mary S Dietrich, Kenneth J Niermann, Sheila H Ridner, and Barbara A Murphy. 2018. “A Randomized Feasibility Trial to Evaluate Use of the Jaw Dynasplint to Prevent Trismus in Patients With Head and Neck Cancer Receiving Primary or Adjuvant Radiation-Based Therapy.” Integrative Cancer Therapies 17 (3): 960–67. doi:10.1177/1534735418784363.